- Home
- HOOK vs BRN Comparison
HOOK vs BRN Comparison
Compare HOOK & BRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- BRN
- Stock Information
- Founded
- HOOK 2011
- BRN 1956
- Country
- HOOK United States
- BRN United States
- Employees
- HOOK N/A
- BRN N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- BRN Oil & Gas Production
- Sector
- HOOK Health Care
- BRN Energy
- Exchange
- HOOK Nasdaq
- BRN Nasdaq
- Market Cap
- HOOK 9.3M
- BRN 13.4M
- IPO Year
- HOOK 2019
- BRN N/A
- Fundamental
- Price
- HOOK $1.47
- BRN $1.32
- Analyst Decision
- HOOK Buy
- BRN
- Analyst Count
- HOOK 4
- BRN 0
- Target Price
- HOOK $10.67
- BRN N/A
- AVG Volume (30 Days)
- HOOK 134.3K
- BRN 6.1K
- Earning Date
- HOOK 05-20-2025
- BRN 05-20-2025
- Dividend Yield
- HOOK N/A
- BRN N/A
- EPS Growth
- HOOK N/A
- BRN N/A
- EPS
- HOOK N/A
- BRN N/A
- Revenue
- HOOK $43,946,000.00
- BRN $20,046,000.00
- Revenue This Year
- HOOK N/A
- BRN N/A
- Revenue Next Year
- HOOK N/A
- BRN N/A
- P/E Ratio
- HOOK N/A
- BRN N/A
- Revenue Growth
- HOOK 118.32
- BRN N/A
- 52 Week Low
- HOOK $0.72
- BRN $1.26
- 52 Week High
- HOOK $10.50
- BRN $3.20
- Technical
- Relative Strength Index (RSI)
- HOOK 67.61
- BRN 37.97
- Support Level
- HOOK $1.14
- BRN $1.31
- Resistance Level
- HOOK $1.67
- BRN $1.39
- Average True Range (ATR)
- HOOK 0.16
- BRN 0.07
- MACD
- HOOK 0.10
- BRN 0.00
- Stochastic Oscillator
- HOOK 78.69
- BRN 6.25
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.